Longeveron (LGVN) Asset Utilization Ratio (2023 - 2026)

Longeveron (LGVN) recorded quarterly Asset Utilization Ratio of 0.08 in Q1 2026, down 16.8% quarter-over-quarter from 0.09 in Q4 2025, and down 19.41% on a YoY basis from 0.1 in Q1 2025.

Longeveron (LGVN) Asset Utilization Ratio (2023 - 2026) Analysis & Trends

Longeveron's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.08 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio fell 19.41% year-over-year to 0.08; the TTM figure through Mar 2026 stood at 0.08 (down 19.41% YoY), while the FY2025 annual figure was 0.07, down 47.33% from the prior year.
  • Asset Utilization Ratio was 0.08 for Q1 2026 at Longeveron, down from 0.09 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.11 in Q2 2025 to a low of 0.04 in Q2 2023.
  • Historically, Asset Utilization Ratio has averaged 0.08 across 4 years, with a median of 0.08 in 2024.
  • The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio surged 129.22% in 2024, then decreased 19.41% in 2026.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.06 in 2023, then surged by 44.17% to 0.09 in 2024, then advanced by 7.69% to 0.09 in 2025, then fell by 16.8% to 0.08 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.08 (Q1 2026), 0.09 (Q4 2025), and 0.09 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 0.08

Historic Data

Download Data
DateValue
Mar 31, 2026 0.08
Dec 31, 2025 0.09
Sep 30, 2025 0.09
Jun 30, 2025 0.11
Mar 31, 2025 0.10
Dec 31, 2024 0.09
Sep 30, 2024 0.08
Jun 30, 2024 0.08
Mar 31, 2024 0.09
Dec 31, 2023 0.06
Sep 30, 2023 0.05
Jun 30, 2023 0.04
Mar 31, 2023 0.04